Literature DB >> 27698929

ENaC/DEG in Tumor Development and Progression.

Cui Liu1, Li-Li Zhu1, Si-Guang Xu2, Hong-Long Ji3, Xiu-Min Li4.   

Abstract

The epithelial Na+ channel/degenerin (ENaC/DEG) superfamily, including the acid-sensing ion channels (ASICs), is characterized by a high degree of similarity in structure but highly diverse in physiological functions. These ion channels have been shown to be important in several physiological functions of normal epithelial cells, including salt homeostasis, fluid transportation and cell mobility. There is increasing evidence suggesting that ENaC/DEG channels are critically engaged in cancer cell biology, such as proliferation, migration, invasion and apoptosis, playing a role in tumor development and progression. In this review, we will discuss recent studies showing the role of ENaC and ASIC channels in epithelial cells and its relationship to the oncogenesis.

Entities:  

Keywords:  ASIC; ENaC; apoptosis; cancer cells.; migration; proliferation

Year:  2016        PMID: 27698929      PMCID: PMC5039373          DOI: 10.7150/jca.15693

Source DB:  PubMed          Journal:  J Cancer        ISSN: 1837-9664            Impact factor:   4.207


Introduction

Epithelium is the most common component of human tissues, which mainly functions in body protection, regulation of fluid homeostasis and exchange, and sensation of external stimuli 1,2. The homeostatic balance between cell regeneration and apoptosis of epithelial cells is under precise control or regulation. Therefore, unrestricted proliferation or apoptosis of epithelial cells can lead to abnormal status and even diseases. Recent studies have revealed that various epithelial ion channels play an important role in the regulation of fluid/ion homeostasis 3. Therefore, the abnormal function in these ion channels may lead to certain congenital diseases 4-10 and human cancers 11-13. The genes encoding the epithelial Na+ channel/degenerin (ENaC/DEG) were firstly discovered in the early 1990s. The ENaC/DEG family includes structurally related acid-sensing ion channels (ASIC). It is well known that one of the major physiological functions of the tight and polarized epithelial monolayer is to actively adjust the turnover and resolution of luminal fluid and the machinery for transepithelial salt and fluid transport is distributed in a polarity-dependent manner. Members of the ENaC/DEG family are widely expressed in epithelia including kidney 14-16, lung 17 and colon 18,19. Several studies have shown that the ENaC/DEG channels are responsible for Na+ uptake and fluid transportation 20 and are necessary to maintain the Na+ balance, fluid balance and homeostasis for epithelial cells. It has been also reported that the members of the ENaC/DEG family sense the mechanical stimuli and respond with membrane depolarization 21. The origin of almost 90% of all human cancers is from abnormal epithelial cell functions. Studies have accumulated evidence to support a role for the ENaC/DEG channels in driving malignant cancer cell behaviors and brain tumors 22, 23. In this review, we will discuss the expression of the ENaC and ASIC channels in tumor cells and their role in tumor development and progression, and highlights them as potential new targets for cancer therapy in the future.

Role of ENaC/DEG in tumor development and progression

Four ENaC subunits, namely α, β, γ and δ, are encoded by the Scnn1 genes 24. The Scnn1 genes have been implicated in oncogenesis 25. ENaC subunits form heterotrimeric complexes that function as constitutively active Na+ channels, with different subunit composition resulting in channels with distinct kinetics. The ENaC channels are widely reported to mediate the transport of Na+ from the lumen into the epithelial cells, through which the cell may migrate. As discussed below, there is increasing evidence to suggest a significant role for the ENaC channels in tumor cells, particularly proliferation, migration and apoptosis.

1. α-ENaC

The α-ENaC has been proposed as an important mediator in the processes of cancer cell proliferation. For example, Maryna et al 26 showed an appreciable and reversible increase in the Na+ conductance in human liver hepatocellular carcinoma HepG2 cells under different degree of hypertonic stress, which could be inhibited by flufenamate and amiloride. These two drugs decreased HepG2 cell proliferation. Similar to treatment with flufenamate and amiloride, knockdown of α-ENaC using small interfering RNA (siRNA) strongly reduced hypertonic stress-induced Na+ currents. FACS analysis showed that silencing of α-ENaC inhibited cell proliferation, due to an increase in the G2/M phase and a decrease in the G1 phase of the cell cycle and furthermore, increased cell apoptosis. Silencing of α-ENaC led to strong reduction in the cell volume as shown using scanning acoustic microscopy. In addition to a role in cancer cell proliferation and apoptosis, α-ENaC has been reported to be involved in promoting cancer cell migration 27-29. The α-ENaC protein expression determined by immunocytochemistry was noticeably elevated at the leading edge of wound that was introduced by scratching to choriocarcinoma BeWo cell monolayer cultured with aldosterone 27. Moreover, in wound healing assays, treatment with amiloride alone had no effect on cell migration but completely prevented aldosterone-induced increase in cell migration. Aldosterone-induced increase in cell migration was also abolished in cells treated with antisense oligonucleotides directed against α-ENaC, but not in cells treated with sense oligonucleotides. Taken together, these results provide evidence to suggest that up-regulation of α-ENaC expression by aldosterone or cancer lesion plays an important role in cancer cell migration and post-injury recovery 27. Mirshahi et al showed that cortical actin structures evinced the major factor affecting the activity of ENaC-like channels that are insensitive to amiloride 30.

2.γ-ENaC

A recent study reports a role for γ-ENaC in mediating hypotonic stress-induced proliferation and apoptosis of inner medulla collecting duct (IMCD) cells 31. As determined by FACS and MTT assays, exposure of IMCD cells to hypotonic stress resulted in significant decrease in cell proliferation and increase in cell apoptosis. Such hypotonic stress-induced effects on cell proliferation and apoptosis were prevented by treatment with 11,12-epoxyeicosatrienoic acids (EET) or adenovirus-mediated overexpression of cytochrome P2C23(CYP), the predominant epoxygenase isoform responsible for EET synthesis in rat kidney. Western blotting analysis demonstrated that the γ-ENaC expression in IMCD cells was significantly up-regulated by hypotonic stress, which was prevented by treatment with EET or overexpression of CYP2C23. These observations have led to the notion that regulation of the γ-ENaC expression represents a molecular mechanism responsible for the anti-apoptotic actions of EETs in IMCD cells under hypotonic stress conditions.

3. δ-ENaC

The δ-ENaC expression was shown in human melanoma G-361 cells using reverse transcription-polymerase chain reaction and cell-based in situ hybridization techniques 32. The δ-ENaC expression has also been documented using immunocytochemistry in human melanoma cells 32. This finding led to the proposal that δ-ENaC is a novel therapeutic target for treating malignant melanoma.

Role of ASICs in tumor development and progression

In addition to ENaC channels, ASICs are members of the ENaC/DEG family. Four different genes are identified, encoding six subunit isoforms, termed ASIC1a, ASIC1b, ASIC2a, ASIC2b, ASIC3 and ASIC4. These subunits can assemble functional hetero/homotrimeric channels that are sensitive to inhibition by amiloride 33.

1. ASIC1

Cheng et al 34 found that overexpression of ASIC1a was associated with tumor cell migration and invasion. Under hypoxic and acidic conditions, an important feature of the tumor microenvironments, the ASIC1a mRNA and protein expression was obviously reduced in human hepatocellular carcinoma SMMC-7721 cells. In contrast, the ASIC1a expression was enhanced in a moderately acidic extracellular environment (e.g., pH 6.5). Therefore, ASIC1a may be overexpressed in hepatocellular carcinoma tissues, which are correlated with the disease development. Silencing of the ASIC1a expression inhibited cancer cell migration and invasion. The study by Ross al 35 identified a cation conductance in D54-MG1 glioma cells, which was absent in normal human astrocytes. This conductance was sensitive to inhibition by psalmotoxin, an ASIC1-specific peptide inhibitor, as well as amiloride, suggesting that it was mediated by ASCI1a. Regulatory volume recovery from hyperosmotic stimulus-induced cell shrinkage was inhibited by replacement of extracellular Na+ with NMDG+ or treatments of cells with amiloride and psalmotoxin. These results support a role for the ASCI1a channel in restoring cell volume during migration of human glioma cells in the brain.

2. ASIC2

An early electrophysiological study documented amiloride-sensitive constitutive currents in cells from high-grade human malignant glioma, but not in cells from low grade tumors or human normal astrocytes 36. In a subsequent study, the same group revealed that surface expression of ASIC2 protein was detected in normal astrocytes but completely absent in high-grade human malignant glioma, immortalized human glioma cells 37. In further experiments, it was shown that treatments with glycerol, a chemical chaperone, or sodium 4-phenylbutyrate, a transcriptional regulator, stimulated trafficking of the intracellularly localized ASIC2 protein to the plasma membrane, leading to significant increase in ASIC2 protein at the cell surface and suppression of amiloride-sensitive currents. Both treatments reduced glioma cell proliferation and migration. These results led to the hypothesis that promotion of the ASIC2 cell surface expression and down-regulation of the amiloride-sensitive channel activity may reverse high-grade glioma cells to cells with normal astrocyte phenotypes. Vascular smooth muscle cell (VSMC) migration is important for vascular genesis and vascular remodeling after injury. A separate study showed that ASIC2 also participated in inhibiting VSMC cell migration 38. Similar to what described above in high-grade glioma cells, ASIC2 was largely retained intracellularly. Treatment with glycerol increased ASIC2 cell surface expression and inhibited platelet-derived growth factor-induced cell migration. Moreover, this study showed that siRNA-mediated silencing of heat shock protein 70 (Hsc70) promoted ASIC2 protein cell surface expression and inhibition of cell migration, which was prevented by silencing of ASIC2 expression. These results suggest that Hsc70-dependent regulation of ASIC2 surface expression is an important regulatory mechanism in the processes of vascular genesis and vascular remodeling.

Conclusions and Future Perspectives

It has been 20 years since ENaC was first molecularly cloned from mouse colonic epithelium. As the earlier studies on the ENaC/DEG channels predominantly focused on their physiological functions in liver, kidney and colon epithelial cells, and showed that ENaC channel function was necessary for homeostasis of water and ion. A number of recent studies have attracted attention to the expression and function of these channels in cancer cells. As discussed above, evidence is emerging to support that the ENaC/DEG channels play a role in tumor development and progression, and stimulation or inhibition of particular ion channel expression and activity may be beneficial in certain disease conditions. Evidently, more efforts are required to better inform the relationships between the ENaC/DEG channels and tumor cells and thereby how to treat tumors by targeting these channels.
  38 in total

Review 1.  Epithelial sodium channel/degenerin family of ion channels: a variety of functions for a shared structure.

Authors:  Stephan Kellenberger; Laurent Schild
Journal:  Physiol Rev       Date:  2002-07       Impact factor: 37.312

2.  Liddle's syndrome mutations increase Na+ transport through dual effects on epithelial Na+ channel surface expression and proteolytic cleavage.

Authors:  Kristin K Knight; Diane R Olson; Ruifeng Zhou; Peter M Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-13       Impact factor: 11.205

3.  Interaction of ASIC1 and ENaC subunits in human glioma cells and rat astrocytes.

Authors:  Niren Kapoor; William Lee; Edlira Clark; Rafal Bartoszewski; Carmel M McNicholas; Cecelia B Latham; Zsuzsanna Bebok; Vladimir Parpura; Catherine M Fuller; Cheryl A Palmer; Dale J Benos
Journal:  Am J Physiol Cell Physiol       Date:  2011-02-23       Impact factor: 4.249

4.  Cystic fibrosis transmembrane regulator (CFTR) in human trophoblast BeWo cells and its relation to cell migration.

Authors:  G I Marino; B A Kotsias
Journal:  Placenta       Date:  2013-12-21       Impact factor: 3.481

5.  Surface expression of ASIC2 inhibits the amiloride-sensitive current and migration of glioma cells.

Authors:  Wanda H Vila-Carriles; Gergely Gy Kovacs; Biljana Jovov; Zhen-Hong Zhou; Amit K Pahwa; Garrett Colby; Ogenna Esimai; G Yancey Gillespie; Timothy B Mapstone; James M Markert; Catherine M Fuller; James K Bubien; Dale J Benos
Journal:  J Biol Chem       Date:  2006-05-16       Impact factor: 5.157

6.  Rab proteins regulate epithelial sodium channel activity in colonic epithelial HT-29 cells.

Authors:  Sunil Saxena; Madhurima Singh; Kathrin Engisch; Mitsunori Fukuda; Simarna Kaur
Journal:  Biochem Biophys Res Commun       Date:  2005-10-07       Impact factor: 3.575

7.  Analysis of calcium ion homeostasis and mitochondrial function in cerebellar granule cells of adult CaV 2.1 calcium ion channel mutant mice.

Authors:  Bhupinder Bawa; Louise C Abbott
Journal:  Neurotox Res       Date:  2008-01       Impact factor: 3.911

8.  Steroid-mediated regulation of the epithelial sodium channel subunits in mammary epithelial cells.

Authors:  Cary Boyd; Anikó Náray-Fejes-Tóth
Journal:  Endocrinology       Date:  2007-05-17       Impact factor: 4.736

9.  Transforming growth factor-beta1 decreases epithelial sodium channel functionality in renal collecting duct cells via a Smad4-dependent pathway.

Authors:  Chiz-Tzung Chang; Cheng-Chieh Hung; Yung-Chang Chen; Tzung-Hai Yen; Mai-Szu Wu; Chih-Wei Yang; Aled Phillips; Ya-Chung Tian
Journal:  Nephrol Dial Transplant       Date:  2007-11-28       Impact factor: 5.992

10.  Epoxyeicosatrienoic acids attenuating hypotonic-induced apoptosis of IMCD cells via γ-ENaC inhibition.

Authors:  Luyun Wang; Yang Liu; Huamin Wang; Xun Liu; Jie Chen; Mong-Heng Wang; Jingfeng Wang; Hui Huang
Journal:  PLoS One       Date:  2014-04-08       Impact factor: 3.240

View more
  12 in total

1.  Identification of Isoform 2 Acid-Sensing Ion Channel Inhibitors as Tool Compounds for Target Validation Studies in CNS.

Authors:  Leda Ivanova Bencheva; Marilenia De Matteo; Luca Ferrante; Marco Ferrara; Adolfo Prandi; Pietro Randazzo; Silvano Ronzoni; Roberta Sinisi; Pierfausto Seneci; Vincenzo Summa; Mariana Gallo; Maria Veneziano; Antonella Cellucci; Nausicaa Mazzocchi; Andrea Menegon; Romano Di Fabio
Journal:  ACS Med Chem Lett       Date:  2019-02-07       Impact factor: 4.345

Review 2.  SGK1: The Dark Side of PI3K Signaling.

Authors:  Antonio Di Cristofano
Journal:  Curr Top Dev Biol       Date:  2016-12-15       Impact factor: 4.897

3.  Low Baseline Serum Sodium Concentration Is Associated with Poor Clinical Outcomes in Metastatic Non-Small Cell Lung Cancer Patients Treated with Immunotherapy.

Authors:  Giovanni Fucà; Giulia Galli; Marta Poggi; Giuseppe Lo Russo; Claudia Proto; Martina Imbimbo; Milena Vitali; Monica Ganzinelli; Claudia Lanti; Giuliano Molino; Fabiano Stangoni; Nicoletta Zilembo; Filippo de Braud; Marina Chiara Garassino; Diego Signorelli
Journal:  Target Oncol       Date:  2018-12       Impact factor: 4.493

4.  The human asparaginase enzyme (ASPG) inhibits growth in leukemic cells.

Authors:  Stefania Belviso; Rodolfo Iuliano; Rosario Amato; Nicola Perrotti; Miranda Menniti
Journal:  PLoS One       Date:  2017-05-24       Impact factor: 3.240

5.  HOXD9‑induced SCNN1A upregulation promotes pancreatic cancer cell proliferation, migration and predicts prognosis by regulating epithelial‑mesenchymal transformation.

Authors:  Jinhai Chang; Xuguang Hu; Jinniang Nan; Xianghua Zhang; Xintian Jin
Journal:  Mol Med Rep       Date:  2021-09-24       Impact factor: 2.952

6.  SGK1 Is a Critical Component of an AKT-Independent Pathway Essential for PI3K-Mediated Tumor Development and Maintenance.

Authors:  Arturo Orlacchio; Michela Ranieri; Martina Brave; Valeria Antico Arciuch; Toni Forde; Daniela De Martino; Karen E Anderson; Phillip Hawkins; Antonio Di Cristofano
Journal:  Cancer Res       Date:  2017-10-20       Impact factor: 12.701

7.  Differential expression of epithelial sodium channels in human RCC associated with the prognosis and tumor stage: Evidence from integrate analysis.

Authors:  Shangfan Liao; Huaibin Huang; Fabiao Zhang; Dongming Lu; Shuchao Ye; Luoping Zheng; Yingming Sun; Yongyang Wu
Journal:  J Cancer       Date:  2020-10-23       Impact factor: 4.207

Review 8.  Alteration and dysfunction of ion channels/transporters in a hypoxic microenvironment results in the development and progression of gastric cancer.

Authors:  Junling Chen; Minglin Zhang; Zhiyuan Ma; Dumin Yuan; Jiaxing Zhu; Biguang Tuo; Taolang Li; Xuemei Liu
Journal:  Cell Oncol (Dordr)       Date:  2021-04-15       Impact factor: 6.730

9.  Overexpression of acid-sensing ion channel 1a (ASIC1a) promotes breast cancer cell proliferation, migration and invasion.

Authors:  Chao Yang; Zhen Zhu; Xueyan Ouyang; Ruihua Yu; Jiawei Wang; Gang Ding; Feng Jiang
Journal:  Transl Cancer Res       Date:  2020-12       Impact factor: 1.241

10.  TMPRSS13 promotes cell survival, invasion, and resistance to drug-induced apoptosis in colorectal cancer.

Authors:  Fausto A Varela; Victoria L Foust; Thomas E Hyland; Kimberley E Sala-Hamrick; Jacob R Mackinder; Carly E Martin; Andrew S Murray; Sokol V Todi; Karin List
Journal:  Sci Rep       Date:  2020-08-17       Impact factor: 4.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.